Family Medicine Doctors in Washington Crossing, PA Accepting Medicare

3 Family Medicine doctors found. Showing 1 - 3

Dr. Charles Candee Whitney Iii, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1121 General Washington Memorial Boulevard, Washington Crossing, PA 18977 Phone: 215-321-1371    Fax: 215-321-1378

Sarah Marzeah Shahrabi, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1240 General Washington Mem Blvd Ste 3, Washington Crossing, PA 18977 Phone: 267-573-0670

Henry Jay Gold, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 57 Mcconkey Dr, Washington Crossing, PA 18977 Phone: 215-321-3224

News Archive

Scientists use novel system to discover sequential firing of neurons

Princeton University researchers have used a novel virtual reality and brain imaging system to detect a form of neural activity underlying how the brain forms short-term memories that are used in making decisions.

Woman can more accurately identify man's sexual orientation during peak ovulation

A new study by psychologists at the University of Toronto and Tufts University shows that a woman can more accurately identify a man's sexual orientation when looking at his face, when she is closest to her time of peak ovulation. Further, having romantic thoughts or a mating goal heightens a woman's ability to discriminate between straight and gay men.

Today's selection of opinions and editorials

For now it appears that Washington's polarizing ways, and public anxiety about change, have again left Americans with the most expensive, least reliable health care system in the developed world. No matter who you are, that's hardly cause to celebrate (1/21).

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.

Read more Medical News

› Verified 2 days ago